Endovascular Treatment Alone Not Beneficial for European Stroke Patients
EVT alone was neither noninferior nor superior to intravenous alteplase plus EVT for functional outcome at 90 days
30 Percent of Hospital-Based Health Care Personnel Unvaccinated
COVID-19 vaccination coverage increased from 36.1 to 60.2 percent from January to April 2021, then slowed, reaching 70.0 percent as of Sept. 15
Ethical Considerations Explored for Aducanumab in Alzheimer Disease
Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid
Caregivers More Likely to Have Subjective Cognitive Decline
Caregivers with SCD more likely than caregivers without SCD to report frequent mental distress, history of depression
Trial Begins of Nasal Vaccine for Alzheimer Disease
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
FDA Approves Virtual Reality System to Ease Back Pain
EaseVRx system uses number of cognitive behavioral therapy methods to achieve pain relief
Many Stroke Survivors Continue to Smoke
Stroke survivors less likely than cancer survivors to quit smoking
Noncontrast CT Can ID Candidates for Mechanical Thrombectomy
For stroke patients with late-presenting large-vessel occlusion, 90-day outcomes similar with selection by noncontrast CT, MRI, CTP
Hypertension May Increase Risk for Late-Onset Epilepsy
After adjustment for prevalent and interim stroke, risk for developing epilepsy increased almost twofold
Progress Made in Reducing Depression During Internship
Increases in sleep hours and use of mental health services, decrease in work hours occurred in parallel to decrease in depressive symptoms
